These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10836930)

  • 1. Thrombocytopenia after iron dextran administration in a patient with severe iron deficiency anemia.
    Go RS; Porrata LF; Call TG
    Ann Intern Med; 2000 Jun; 132(11):925. PubMed ID: 10836930
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe intravascular haemolysis and acute renal failure following intravenous administration of iron dextran.
    Buus NH; Jensen JD
    Nephrol Dial Transplant; 2007 Feb; 22(2):661-2. PubMed ID: 16968716
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicity of parenteral iron dextran therapy.
    Burns DL; Pomposelli JJ
    Kidney Int Suppl; 1999 Mar; 69():S119-24. PubMed ID: 10084295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.
    Auerbach M; Pappadakis JA; Bahrain H; Auerbach SA; Ballard H; Dahl NV
    Am J Hematol; 2011 Oct; 86(10):860-2. PubMed ID: 21922526
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous or oral iron?
    Littlewood TJ
    Am J Hematol; 2012 Feb; 87(2):134-5. PubMed ID: 22139596
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral iron dextran therapy: a review.
    Burns DL; Mascioli EA; Bistrian BR
    Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to iron sucrose in dialysis patients sensitive to iron dextran.
    Gupta A; Khaira A; Dogra M; Agarwal SK
    Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):744-5; author reply 745. PubMed ID: 20587886
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parenteral iron replacement].
    Cynke E
    Praxis (Bern 1994); 1997 May; 86(20):835-6. PubMed ID: 9312810
    [No Abstract]   [Full Text] [Related]  

  • 9. Safe administration of iron dextran to a patient who reacted to the test dose.
    Monaghan MS; Glasco G; St John G; Bradsher RW; Olsen KM
    South Med J; 1994 Oct; 87(10):1010-2. PubMed ID: 7939912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should intravenous iron be upfront therapy for iron deficiency anemia?
    Auerbach M
    Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical update: intravenous iron for anaemia.
    Auerbach M; Ballard H; Glaspy J
    Lancet; 2007 May; 369(9572):1502-1504. PubMed ID: 17482969
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion medicine illustrated. Pseudohemolysis with iron dextran therapy.
    Brecher ME; Hay SN
    Transfusion; 2002 Feb; 42(2):135. PubMed ID: 11896324
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
    Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
    Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the use of parenteral iron in end-stage renal disease patients: focus on issues of infection and cardiovascular disease. Introduction.
    Owen WF
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S1-2. PubMed ID: 10516368
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran.
    Freter S; Davidman M; Lipman M; Bercovitch D
    Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral iron therapy options.
    Silverstein SB; Rodgers GM
    Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy.
    Wong L; Smith S; Gilstrop M; Derman R; Auerbach S; London N; Lenowitz S; Bahrain H; McClintock J; Auerbach M
    Am J Hematol; 2016 Jun; 91(6):590-3. PubMed ID: 26971581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical perspective: iron replacement therapy in chronic heart failure.
    Cowie MR; Lucas R
    Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
    Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.